This week, the Saclay campus hosted the inauguration of the Spartners research site, owned by Servier, the second-largest pharmaceutical company in France, and operated by Biolabs, a company based in Boston, US.
On this occasion, GEG Tech, adVentures’ French deeptech company, was selected by Servier and Biolabs to be showcased as an example of cutting-edge innovation within the Paris-Saclay cluster.
GEG Tech is an advanced deeptech company focusing on future therapies and has established partnerships with world-renowned laboratories in the US, EU, Switzerland, and Asia.
Servier and Biolabs produced a video featuring GEG Tech, including an interview with its Research Director, Nicolas Grandchamp. You can watch the video below:
This communication follows the research published by the University of California (Irvine), which uses French technology to restore vision in mice mimicking a human genetic retinal disease (press release available soon).
It also follows the announcement of a partnership between Servier and GEG Tech (article attached), which will be the subject of a joint interview between Servier’s Open Innovation Director, Céline Triquel, and GEG Tech’s Scientific Director, Nicolas Grandchamp. The video will be published by Servier on June 18 2025.
GEG Tech is an emerging success story from the Paris-Saclay hub, ranked first in Europe.
GEG-Tech’s Saclay Plateau Laboratory
